Home > Pharmacy > Pharmacology > Volume-9 > Issue-5 > Drug Repurposing for Neurodegenerative Diseases Using AI and Pharmacogenomic Approaches

Drug Repurposing for Neurodegenerative Diseases Using AI and Pharmacogenomic Approaches

Call for Papers

Volume-10 | Issue-1

Last date : 24-Feb-2026

Best International Journal
Open Access | Peer Reviewed | Best International Journal | Indexing & IF | 24*7 Support | Dedicated Qualified Team | Rapid Publication Process | International Editor, Reviewer Board | Attractive User Interface with Easy Navigation

Journal Type : Open Access

First Update : Within 7 Days after submittion

Submit Paper Online

For Author

Research Area


Drug Repurposing for Neurodegenerative Diseases Using AI and Pharmacogenomic Approaches


Shaziya Noor | Dr. Sharmin Siddiqui | Mohammad Rehan



Shaziya Noor | Dr. Sharmin Siddiqui | Mohammad Rehan "Drug Repurposing for Neurodegenerative Diseases Using AI and Pharmacogenomic Approaches" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-9 | Issue-5, October 2025, pp.729-736, URL: https://www.ijtsrd.com/papers/ijtsrd97549.pdf

Neurodegenerative diseases (NDs), such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), are characterized by progressive neuronal dysfunction and loss, leading to cognitive and motor impairments. Despite decades of research, effective disease-modifying therapies remain elusive, mainly due to complex pathophysiology, genetic heterogeneity, and translational challenges in drug discovery. Drug repurposing identifying novel therapeutic applications for existing drugs offers an efficient, cost-effective, and faster route for therapy development. Advances in artificial intelligence (AI) and pharmacogenomics are transforming this paradigm by enabling integrative data mining, predictive modeling, and patient stratification. This review highlights recent developments in AI-driven drug repurposing pipelines, the role of pharmacogenomic profiling in precision medicine, and emerging case studies demonstrating successful application of these approaches. Finally, we discuss future opportunities and challenges in integrating AI and pharmacogenomics to establish a robust framework for personalized therapeutics in neurodegeneration.

Neurodegenerative diseases, Drug repurposing, Artificial intelligence, Pharmacogenomics, Precision medicine.


IJTSRD97549
Volume-9 | Issue-5, October 2025
729-736
IJTSRD | www.ijtsrd.com | E-ISSN 2456-6470
Copyright © 2019 by author(s) and International Journal of Trend in Scientific Research and Development Journal. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (http://creativecommons.org/licenses/by/4.0)

International Journal of Trend in Scientific Research and Development - IJTSRD having online ISSN 2456-6470. IJTSRD is a leading Open Access, Peer-Reviewed International Journal which provides rapid publication of your research articles and aims to promote the theory and practice along with knowledge sharing between researchers, developers, engineers, students, and practitioners working in and around the world in many areas like Sciences, Technology, Innovation, Engineering, Agriculture, Management and many more and it is recommended by all Universities, review articles and short communications in all subjects. IJTSRD running an International Journal who are proving quality publication of peer reviewed and refereed international journals from diverse fields that emphasizes new research, development and their applications. IJTSRD provides an online access to exchange your research work, technical notes & surveying results among professionals throughout the world in e-journals. IJTSRD is a fastest growing and dynamic professional organization. The aim of this organization is to provide access not only to world class research resources, but through its professionals aim to bring in a significant transformation in the real of open access journals and online publishing.

Thomson Reuters
Google Scholer
Academia.edu

ResearchBib
Scribd.com
archive

PdfSR
issuu
Slideshare

WorldJournalAlerts
Twitter
Linkedin